SureTrader SureTrader
Home > Boards > Other Markets > Foreign Stock Markets >

PAION AG Aachen (PA8)

PA8 RSS Feed
Add PA8 Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 10/6/2016 5:07:41 PM - Followers: 0 - Board type: Free - Posts Today: 0

 

About PAION

PAION is a biopharmaceutical company headquartered in Aachen, Germany and has a second site in Cambridge, UK.

The company is focusing on the clinical development of drug candidates for diseases or interventions for which there is a substantial unmet medical need. After proof of concept in humans the strategy is to out-license or co-develop the drug candidates with pharma partners. Thus revenues can be generated at an early stage, decreasing development costs and risks. The company further profits from the receipt of payments for reaching clinical and commercial milestones and receiving royalties after market approval of the drugs. Further upside can be generated from co-commercialisation activities.

PAION is listed at the Frankfurt Stock Exchange (Prime Standard Regulated Market, Stock Symbol PA8, ISIN DE000A0B65S3).

Download the PAION brochure (310 KB)

 vfa

 

 PAION is a member of the German Association of Research-Based Pharmaceutical Companies (vfa). Further information on vfa is available here: http://www.vfa.de/en

 europeanstrokenetwork

 

PAION is a member of the European Stroke Network (ESN)
Further information on ESN is available here:
http://www.europeanstrokenetwork.eu/

Development Projects

100812_pipeline_en

http://www.paion.de/en/

 

 

November 19, 2010

PAION reports positive results of its short acting anaesthetic/sedative Remimazolam (CNS 7056) in a Phase IIb study

http://www.paion.de/images/stories/investoren/finanznachrichten/2010/en/paiona101119en.pdf 

  

Conference Call - Monday, November 22, 2010

http://www.paion.de/images/stories/investoren/finanznachrichten/2010/en/paionp101122en.pdf

 

Investors' conferences - Tuesday, November 23, 2010

http://www.eigenkapitalforum.com/upload/9_i_en.pdf

 

 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PA8
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#22   REMIMAZOLAM PHASE III COLONOS Leff0815 10/06/16 05:07:41 PM
#21   Hello gyus, loschek 01/06/15 04:17:35 AM
#20   Echt warst du dort? dann haben wir uns Raphael90 09/19/14 07:17:38 PM
#19   This will test 7€ next week ..... WaVe444 02/16/14 07:38:37 AM
#18   und wie wars ? Fortunato69 02/15/14 03:43:24 AM
#17   Heute bin ich bei Paion in der Hauptverwaltung Packardbell 02/10/14 07:04:23 PM
#16   Are you from Germany ? You will Be Fortunato69 04/19/11 08:22:38 AM
#15   Conference Call - November 22, 2010 rikic 11/22/10 03:45:43 AM
#14   PAION reports positive results of its short acting rikic 11/19/10 10:17:00 AM
#13   I have no US Stocks in my portfolio, erbse24448 11/16/10 11:29:18 AM
#12   I have not other favourite bio stocks from rikic 11/16/10 10:51:35 AM
#11   Hi rikic, erbse24448 11/16/10 10:05:51 AM
#10   Hi Erbse, rikic 11/16/10 08:37:46 AM
#9   Hi rikic, erbse24448 11/16/10 07:25:10 AM
#8   You are welcome, Erbse. rikic 11/16/10 03:33:28 AM
#7   Hallo rikic erbse24448 11/11/10 11:13:39 AM
#6   PA8 is today's Trade Alert with +500% potential! rikic 11/11/10 06:18:18 AM
#5   Get ready for results Phase IIb - Remimazolam rikic 11/10/10 11:55:32 AM
#4   RESULTS BY THE END OF THE NOVEMBER 2010. rikic 10/20/10 05:53:00 AM
#3   Paion AG Expands Desmoteplase License Agreement with its rikic 10/18/10 04:34:17 AM
#2   Analyst Presentation at German Equity Forum Fall 2010, rikic 10/13/10 07:18:37 AM
#1   PAION COMPLETES PHASE IIB STUDY WITH SHORT-ACTING rikic 10/13/10 06:33:54 AM
PostSubject